Semax as a Universal Drug for Therapy and Research


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

In this review, based on published experimental and clinical data (1980‒2016), a comparative analysis of the structures and effects of Semax (peptide drug) and its analogue fragments was carried out. The effect of these oligopeptides on various body systems is examined. The multiple effects of Semax for a number of diseases have been collected for a single scheme of corrective processes. The rationale for the long-term therapeutic effects of this peptide drug is presented. A comparative analysis of the temporal dynamics of the expression of certain genes is carried out.

Sobre autores

S. Koroleva

Institute of Molecular Genetics, Russian Academy of Sciences

Autor responsável pela correspondência
Email: svr.koroleva@gmail.com
Rússia, Moscow, 123182

N. Myasoedov

Institute of Molecular Genetics, Russian Academy of Sciences

Email: svr.koroleva@gmail.com
Rússia, Moscow, 123182

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Pleiades Publishing, Inc., 2018